Ariad Opts For Poison Pill After Hedge Fund Buy-In
Ariad Pharmaceuticals Inc. on Friday said it has adopted a poison pill plan to protect itself from unsolicited takeover plays, a move that comes after fledgling activist hedge fund Sarissa Capital...To view the full article, register now.
Already a subscriber? Click here to view full article